steer study semaglutide Adith Arun on X: "Three reasons why the #ESC2025 of 2.4 mg versus tirzepatide is not appropriate for drawing conclusions: 1. Semaglutide 2.4 mg should be compared against tirzepatide ESC 2025: Novo Nordisk's Wegovy

Some patients may experience changes in skin texture or looseness related to rapid weight lossa common outcome of GLP-1 receptor agonist therapywhich should not be confused with allergic drug reactions

Not all patients will experience constipation while taking GLP-1 medications

Studies have observed that GLP-1RA decreases food intake, slows gastric emptying, and promotes the release of hormones such as leptin and peptide YY, involved in satiety (7)

Peptides are short chains of the same amino acids that link up to make proteins

The magnitude of results approached levels previously seen only with bariatric surgery

FDA lists some compounds it carries: Salt forms like semaglutide sodium or acetate Cyanocobalamin Vitamin B12 Pyridoxine Vitamin B6 Levocarnitine Nicotinamide adenine dinucleotide The formulation varies based on the patients requirements and conditions